Since 2020, Dr. Zadno has led the Company through significant growth and commercial expansion, including adoption and utilization of Aquablation® therapy for the treatment of BPH, the Company’s ...

Conference Call and Webcast scheduled for tomorrow, July 25, 2025 at 10:00 am PT. SAN JUAN CAPISTRANO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: EN ...

Rakovina Therapeutics Inc. (TSXV: RKV) (the “ Company ” or “ Rakovina ”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased ...

About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, ...

The filing of the preliminary proxy statement follows the trading suspension of the Company’s common stock due to non-compliance with Nasdaq’s minimum bid price requirements. Vaxart appealed the ...

Complete financial results are available in HeartSciences’ Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission on July 24, 2025, and accessible via the Company’s website ...

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live ...

Fairhaven Health has developed a highly curated line of multivitamins tailored to each stage of a woman’s life — paired with ...

“Connectomics is the future of brain care, and Omniscient is the only company bringing this vision to life at scale,” said Arie Henkin, Chief Clinical Officer at Omniscient. “This partnership allows ...

Villepinte, le 24 juillet 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, publie son chiffre d’affaires du premier ...

During the showcase, Merakris CEO Chris Broderick presented MTX-001, a first-in-class injectable biologic drug therapy derived from purified amniotic fluid for the treatment of non-healing venous leg ...

Villepinte, July 24, 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is publishing its revenue for the first half of the year.